Exelixis (NASDAQ:EXEL) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0.36 by 72.22 percent. This is a 264.71 percent increase over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $555.45 million which beat the analyst consensus estimate of $498.18 million by 11.50 percent. This is a 30.62 percent increase over sales of $425.23 million the same period last year.